Thursday, January 28, 2021
Home 2019 November

Monthly Archives: November 2019

Mitesco, Biotech Stock Review
Incubator

True Nature (TNTY), a Medtech Startup Incubator Pays Down Some Toxic...

Editor / Curator -
Biotech News

Frontier Bio (FBIO) Bolstering it’s Warchest.

Editor / Curator -
True Nature, Mitesco, Biotech Stock Review
Incubator

Is True Nature (TNTY) $0.04, Nearing a Breakout?

Editor / Curator -
True Nature, Mitesco, Biotech Stock Review
Accelerator

True Nature’s (TNTY) CEO Larry Diamond on Wall Street Analyzer.

Editor / Curator -
AR THreats Report, Biotech Stock Reciew
Superbug News - CoronaVirus Watch List

AR Threats Report (CDC)

Editor / Curator -
biogen, biotech stock review
Biotech News

Biotech’s Turning Up…

Editor / Curator -
True Nature, Biotech Stock Review
Accelerator

True Nature | Mitesco (TNTY), Perking Up.

Editor / Curator -
Dyadic, Biotech Stock Review
Biotech News

Dyadic (DYAI) Highlights.

Editor / Curator -
Mustang Bio, Biotech Stock Review
Biotech News

Mustang Bio (MBIO) Highlights.

Editor / Curator -
Stand Down.

Stand Down IV: Remember This? Alta Vista Cancels IPO. David Wetherell...

Editor / Curator -
12Page 1 of 2

Latest article

Citius, Biotech Stock Review

Adding Citius Pharma (CTXR) $1.29 to the 2021 Biotech Portfolio.

2020 Watch List Editor / Curator -
The 2021 Biotech Six Pack, Six Stocks We Expect to Double. We're still putting the 2021 list together now,...
Mitesco, Biotech Stock Review, roland rick perry

Short Squeeze Mania.

2020 Watch List Editor / Curator -
Citius Pharma (CTXR) Locked and Loaded. Truly Locked and Loaded. Latest $20 Million Round is Biggest News We've Seen...

Video: Pacific Stem Cell

Stem Cells Editor / Curator -
With nearly a third of the US suffering from chronic pain, and over a million patients a year having joint replacements, affordable...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: roland@institutionalanalyst.com
© Managed by Revelers.IO Media Group Inc.